ezogabine has been researched along with Neuralgia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amato, GS; Burns, JF; Eargle, CW; Fritch, PC; Harrison, W; Jones, L; McNaughton-Smith, G; Roeloffs, R; Wickenden, AD | 1 |
| Boissard, CG; Bourin, C; Calandra, V; Chen, J; Chen, P; Conway, CM; Davis, CD; Dworetzky, SI; Fitzpatrick, W; Gribkoff, VK; Harden, DG; He, H; Heman, K; Knox, RJ; Machet, F; Natale, J; Polino, JL; Starrett, JE; Sun, LQ; Thompson, MW; Weaver, D; Wu, YJ | 1 |
| Dang, D; Frost, JA; Li, J; Li, L; Yang, Q; Zuo, Y | 1 |
| Bhatnagar, A; Garg, S; Kumar, A; Pottabathini, R | 1 |
| Bernal, L; Lopez-Garcia, JA; Roza, C | 1 |
| Blackburn-Munro, G; Jensen, BS | 1 |
6 other study(ies) available for ezogabine and Neuralgia
| Article | Year |
|---|---|
Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.
Topics: Adamantane; Animals; Azides; Epilepsy; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Mice; Neuralgia; Structure-Activity Relationship | 2010 |
Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain.
Topics: Acrylamides; Animals; KCNQ2 Potassium Channel; Male; Neuralgia; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley | 2013 |
Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carbamates; Cell Line, Tumor; Drug Repositioning; Humans; KCNQ Potassium Channels; Male; Neuralgia; Neurons; Neuroprotective Agents; Paclitaxel; Peripheral Nervous System Diseases; Phenylenediamines; Random Allocation; Rats, Sprague-Dawley | 2019 |
Possible involvement of nitric oxide modulatory mechanism in the protective effect of retigabine against spinal nerve ligation-induced neuropathic pain.
Topics: Animals; Carbamates; Ligation; Male; Neuralgia; Neuroprotective Agents; Nitric Oxide; Pain Threshold; Phenylenediamines; Rats; Rats, Sprague-Dawley; Spinal Nerves | 2015 |
Spontaneous activity in C-fibres after partial damage to the saphenous nerve in mice: Effects of retigabine.
Topics: Action Potentials; Animals; Axotomy; Carbamates; Disease Models, Animal; Male; Membrane Transport Modulators; Mice; Nerve Fibers; Neuralgia; Neuroma; Peripheral Nerves; Phenylenediamines | 2016 |
The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain.
Topics: Animals; Anthracenes; Anticonvulsants; Behavior, Animal; Carbamates; Disease Models, Animal; Dose-Response Relationship, Drug; Hindlimb; Male; Neuralgia; Pain Measurement; Phenylenediamines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Time Factors | 2003 |